CRISPR Gene Editing Newsletter
Issue #51August 24, 20267 studies

Virus-like particles just unlocked CRISPR screening in immune cells that were nearly impossible to edit

Myeloid immune cells — the macrophages and dendritic cells that patrol your body — have been stubbornly resistant to the gene-editing tools that work everywhere else.

A new delivery system just changed that, and the first screens it ran turned up a surprising master switch for inflammation.

🧫 A New Toolkit Cracks Open the Hardest Immune Cells to Edit

  • Researchers built a virus-like particle (VLP) system that delivers CRISPR machinery — knockouts, base edits, epigenetic silencing — into human monocytes, macrophages, and dendritic cells with high efficiency while keeping the cells alive and immunologically functional.
  • They then ran pooled loss-of-function screens across human macrophages and landed on TNFAIP3 as a central regulator of inflammatory polarization: knock it out and macrophages lock into a pro-inflammatory state that resists suppressive signals and kills tumor cells more aggressively.
  • The same platform, paired with a viral donor delivery method, also enabled large DNA insertions via homology-directed repair — something previously out of reach in primary myeloid cells at scale.

Why it matters: Myeloid cells are increasingly targeted for cancer immunotherapy, but engineering them has lagged far behind T-cell approaches. This toolkit gives researchers a scalable way to run unbiased functional screens in the actual cells they want to use as therapies.

🏆 Top 0.1% journal 🔗 Nature biotechnology Journal Article 🗓️ Aug 18

Key Findings

🩹 A Smart Bandage Edits Genes Inside an Infected Wound

  • A hydrogel patch anchors CRISPR proteins on its surface rather than burying them in the gel, then releases them in response to the acidic environment of a bacterial infection — achieving over 20% gene editing efficiency directly in wound tissue in mice infected with Staph aureus.
  • The target was the NLRP3 inflammasome, a driver of runaway inflammatory injury, and edited wounds showed significantly reduced inflammatory cell infiltration compared to controls.
💡 pH-triggered surface release may be the cleanest localized gene-editing delivery yet.
🥉 Top 5% journal 🔗 Materials horizons Journal Article 🗓️ Aug 19

🖊️ Prime Editing Just Mapped a Full Mouse from Fertilized Egg to Organ Formation

  • Using a prime editing-based recorder called DNA Typewriter, researchers traced mouse development from a single fertilized cell through day 13.5 of embryogenesis, reconstructing a time-calibrated cell lineage tree of over 1.3 million annotated cells from one embryo.
  • Sibling cells shared the same cell type 9-fold more often than chance alone would predict — rising to 68- to 107-fold for cell types from spatially restricted founder pools — and a small cohort of pre-gastrulation founders dominated the embryo despite remaining broadly multipotent.
💡 The most detailed mammalian cell family tree ever built, from a single embryo.

💊 CRISPR's First Approved Therapy Works — Getting It to Patients Is the Hard Part

  • A clinical review of exagamglogene autotemcel, the first FDA-approved CRISPR therapy, details durable freedom from severe vaso-occlusive crises in sickle cell disease and sustained transfusion independence in beta-thalassemia — but flags that successful delivery requires over a dozen coordinated steps from referral through years of follow-up.
  • Key barriers named: stem cell collection difficulty, myeloablative conditioning toxicity, cost, reimbursement friction, and persistent access inequities — none of which are solved by editing efficacy alone.
💡 A curative gene edit means nothing if the care infrastructure can't support it.
🥉 Top 5% journal 🔗 JCO oncology practice Review 🗓️ Aug 19

🔬 A New Platform Assigns Function to Hundreds of Chemical-Protein Interactions at Once

  • ESCAPE uses prime editing to swap out specific cysteines in proteins, then measures how that swap changes a cell's response to a covalent drug — producing a resistance score that reveals whether that particular chemical-protein contact actually matters for cell survival.
  • Applied across 50+ proteins, the platform identified multiple interactions that impair cancer cell growth, including one that disrupts ribosome assembly by targeting an RNA helicase called DDX49 at a site that isn't the enzyme's active center.
💡 Functional scores for covalent drugs, at scale, without guessing which protein contact counts.

🌡️ A Popular Gene-Silencing Tool Fails at High Temperatures

  • Genome-wide screens in Bacillus subtilis showed that the most widely used CRISPRi system — built on Streptococcus pyogenes Cas9 — produces very little gene repression at 45°C, a finding confirmed at the single-cell level using fluorescent reporters.
  • The implication is direct: experiments in thermophilic bacteria or heat-shock conditions in standard lab strains using this system may be generating systematically misleading results.
💡 Thousands of CRISPRi experiments may need a temperature caveat attached.
Top 20% journal 🔗 mSphere Journal Article 🗓️ Aug 19

🥒 Prime Editing in Crops Just Got an 80% Success Rate

  • An optimized prime editing system achieved an average desired editing frequency of 80.83% across targeted sites in cucumber — with some sites hitting 100% — by combining a ribonuclease that processes guide RNAs, a stronger promoter, and a new selection antibiotic during transformation.
  • The team used the system to generate cucumber lines with dual resistance to bacterial angular leaf spot and downy mildew, with edits that passed to the next generation.
💡 Crop prime editing just cleared the efficiency bar that made it impractical in vegetables.
🥈 Top 2% journal 🔗 Journal of integrative plant biology Journal Article 🗓️ Aug 19

Implications

CRISPR is no longer one tool — it's a family of editors, silencers, recorders, and detectors deployed across cells, wounds, embryos, and fields. The unresolved tension: as delivery systems grow more sophisticated, the gap between what editing can do in a lab and what health systems can actually administer to patients keeps widening.

Studies in this issue

Primary sources used for this newsletter.

  1. ESCAPE: Identifying how specific molecules bind to targets in cells using precise gene editing
    key findingbioRxiv : the preprint server for biology2026-08-20PMID 42619774
  2. A hydrogel patch that delivers CRISPR gene editing directly to inflamed wounds
    key findingMaterials horizons2026-08-19PMID 42614060
  3. Using CRISPR gene editing as a new treatment for blood disorders and some cancers
    key findingJCO oncology practice2026-08-19PMID 42617141
  4. A precise gene editing method for cucurbits helps breed cucumbers resistant to multiple diseases
    key findingJournal of integrative plant biology2026-08-19PMID 42614027
  5. Tracing cell development in a growing mouse from fertilized egg to late organ formation using DNA Typewriter
    key findingbioRxiv : the preprint server for biology2026-08-20PMID 42619846